CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy
Clinical trial NCT07443826 · RECRUITING
Trial details
- NCT number
- NCT07443826
- Sponsor
- Unlimited Biotechnology LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-09-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.